Search Results - "MUNSELL, Mark F"

Refine Results
  1. 1

    A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer by Soliman, Pamela T, Westin, Shannon N, Dioun, Shayan, Sun, Charlotte C, Euscher, Elizabeth, Munsell, Mark F, Fleming, Nicole D, Levenback, Charles, Frumovitz, Michael, Ramirez, Pedro T, Lu, Karen H

    Published in Gynecologic oncology (01-08-2017)
    “…Highlights • Sentinel lymph detection rates were 89% in high risk patients. • The sensitivity of SLN was 95% in high-risk endometrial cancer. • The FNR of SLN…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Role of Minimally Invasive Surgery in Gynecologic Oncology: An Updated Survey of Members of the Society of Gynecologic Oncology by Conrad, Lesley B, Ramirez, Pedro T, Burke, William, Naumann, R Wendel, Ring, Kari L, Munsell, Mark F, Frumovitz, Michael

    “…To evaluate the current patterns of use of minimally invasive surgical procedures, including traditional, robotic-assisted, and single-port laparoscopy, by…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Significance of lymph node ratio in defining risk category in node-positive early stage cervical cancer by Fleming, Nicole D, Frumovitz, Michael, Schmeler, Kathleen M, dos Reis, Ricardo, Munsell, Mark F, Eifel, Patricia J, Soliman, Pamela T, Nick, Alpa M, Westin, Shannon N, Ramirez, Pedro T

    Published in Gynecologic oncology (01-01-2015)
    “…Abstract Objective The ratio of positive to negative lymph nodes, or lymph node ratio (LNR), is an important prognostic factor in several solid tumors. The…”
    Get full text
    Journal Article
  9. 9

    Lymphovascular Space Invasion Portends Poor Prognosis in Low-Risk Endometrial Cancer by dos Reis, Ricardo, Burzawa, Jennifer K, Tsunoda, Audrey T, Hosaka, Masayoshi, Frumovitz, Michael, Westin, Shannon N, Munsell, Mark F, Ramirez, Pedro T

    “…The prognostic significance of lymphovascular space invasion (LVSI) in patients with early-stage endometrial cancer is not established. We sought to determine…”
    Get more information
    Journal Article
  10. 10

    Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML by Zeng, Zhihong, Sarbassov, Dos D., Samudio, Ismael J., Yee, Karen W.L., Munsell, Mark F., Ellen Jackson, C., Giles, Francis J., Sabatini, David M., Andreeff, Michael, Konopleva, Marina

    Published in Blood (15-04-2007)
    “…The mTOR complex 2 (mTORC2) containing mTOR and rictor is thought to be rapamycin insensitive and was recently shown to regulate the prosurvival kinase AKT by…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Physician pain and discomfort during minimally invasive gynecologic cancer surgery by McDonald, Megan E, Ramirez, Pedro T, Munsell, Mark F, Greer, Marilyn, Burke, William M, Naumann, Wendel T, Frumovitz, Michael

    Published in Gynecologic oncology (01-08-2014)
    “…Abstract Objective Despite increasing awareness of physical strain to surgeons associated with minimally invasive surgery (MIS), its use continues to expand…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Factors prognostic of survival in advanced-stage uterine serous carcinoma by Holman, Laura L, Pal, Navdeep, Iglesias, David A, Soliman, Pamela T, Balakrishnan, Nyla, Klopp, Ann, Broaddus, Russell R, Fleming, Nicole D, Munsell, Mark F, Lu, Karen H, Westin, Shannon N

    Published in Gynecologic oncology (01-07-2017)
    “…Abstract Objectives The study objective was to analyze the impact of prognostic factors, including treatment modality, on outcome in patients with…”
    Get full text
    Journal Article
  17. 17

    Carcinoma of the Bartholin Gland: A Review of 33 Cases by Bhalwal, Asha B, Nick, Alpa M, Dos Reis, Ricardo, Chen, Chun-Ling, Munsell, Mark F, Ramalingam, Preetha, Salcedo, Mila Pontremoli, Ramirez, Pedro T, Sood, Anil K, Schmeler, Kathleen M

    “…Primary carcinoma of the Bartholin gland is a rare malignancy that accounts for approximately 5% of vulvar carcinomas. The aim of the study was to compare the…”
    Get more information
    Journal Article
  18. 18

    Abnormal Uterine Bleeding as the Presenting Symptom of Hematologic Cancer by Nebgen, Denise R, Rhodes, Helen E, Hartman, Cynthia, Munsell, Mark F, Lu, Karen H

    Published in Obstetrics and gynecology (New York. 1953) (01-08-2016)
    “…OBJECTIVE:To estimate the percentage of women with a hematologic cancer who present with abnormal uterine bleeding (AUB). METHODS:We performed a retrospective…”
    Get full text
    Journal Article
  19. 19

    Thirty‐day hospital readmission rate, reasons, and risk factors after acute inpatient cancer rehabilitation by Tennison, Jegy M., Rianon, Nahid J., Manzano, Joanna G., Munsell, Mark F., George, Marina C., Bruera, Eduardo

    Published in Cancer medicine (Malden, MA) (01-09-2021)
    “…Objectives To evaluate the 30‐day hospital readmission rate, reasons, and risk factors for patients with cancer who were discharged to home setting after acute…”
    Get full text
    Journal Article
  20. 20

    Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinoma by MALPICA, Anais, DEAVERS, Michael T, TORNOS, Carmen, KURMAN, Robert J, SOSLOW, Robert, SEIDMAN, Jeffrey D, MUNSELL, Mark F, GAERTNER, Erich, FRISHBERG, David, SILVA, Elvio G

    Published in The American journal of surgical pathology (01-08-2007)
    “…Although grading has been demonstrated to be an important prognostic factor in ovarian serous carcinoma, there is no system universally used to perform this…”
    Get full text
    Journal Article